US Selumetinib Registry
Clinical trial NCT05683678 · TERMINATED
Trial details
- NCT number
- NCT05683678
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-04
- Primary completion
- 2024-11-13
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.